SARS-CoV-2 and chronic myeloid leukemia: a systematic review
EA Ali, A Al-Sadi, Q Al-Maharmeh, EA Subahi… - Frontiers in …, 2024 - frontiersin.org
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
causing the coronavirus disease of 2019. The disease has caused millions of deaths since …
causing the coronavirus disease of 2019. The disease has caused millions of deaths since …
Comprehensive assessment of COVID-19 case fatality rate and influential factors in Khuzestan Province, Iran: a two-year study
Background The emergence of a new pandemic SARS-CoV-2 (COVID-19) resulted in a high
mortality rate across the world. This study sought to comprehensively analyze the Case …
mortality rate across the world. This study sought to comprehensively analyze the Case …
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Since the beginning of the COVID-19 pandemic, there has been an overall improvement in
patient mortality. However, haematological malignancy patients continue to experience …
patient mortality. However, haematological malignancy patients continue to experience …
[HTML][HTML] Chronic Myeloid Leukemia in Bulgaria in the New Millennium: Identification of Directions for Improvement in Management and Outcomes Reporting
V Shivarov, D Grigorova, M Nedeva, T Milkov… - Hemato, 2024 - mdpi.com
Background: In the last two decades, tyrosine kinase inhibitors (TKIs) and advances in
molecular diagnostics have revolutionized management and long-term clinical outcomes in …
molecular diagnostics have revolutionized management and long-term clinical outcomes in …